Date: 2014-09-11 16:49:00Immune system Immunology Allergology Monoclonal antibodies Granulocytes Omalizumab Immunoglobulin E Allergy FcεRI Biology Medicine Anatomy | | XOLAIR® CRITERIA Pharmacology: Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Reduction in surface-bound IgE on FceRI-bearing cells limits thAdd to Reading ListSource URL: www.nhhealthyfamilies.comDownload Document from Source Website File Size: 24,36 KBShare Document on Facebook
|